Related Experiment Videos
[Familial Mediterranean fever]
1Kinderklinik Marienhospitals Witten.
Abstract:
Familial Mediterranean Fever is a genetically determined disease occurring predominantly in Arabs, Armenians, Jews and very rarely in Turks. It is characterized by moderately elevated body temperature and by abdominal, pulmonary or arthritic complaints. These symptoms are recurrent appearing at short intervals and persisting for not more than two days. Renal amyloidosis may be a complication. Thus, treatment should be continued for life. The pathomechanism of the disease is not clear. Colchicine has been shown to give good symptomatic relief. Surprisingly, the prolonged use of this mitotic poison is virtually devoid of untoward side effects, even in pregnancy and childhood.
Insights
Familial Mediterranean Fever (FMF) is a genetic disorder causing recurrent fevers and pain. Colchicine offers effective, safe long-term symptom relief, even in vulnerable populations.
Area of Science:
- Genetics
- Rheumatology
- Internal Medicine
Background:
- Familial Mediterranean Fever (FMF) is a rare, inherited autoinflammatory disorder.
- Primarily affects individuals of Arab, Armenian, and Jewish descent.
- Characterized by recurrent episodes of fever and serositis.
Observation:
- Symptoms include fever, abdominal pain, arthritis, or chest pain.
- Attacks are short-lived, typically lasting no more than two days.
- Potential complication includes renal amyloidosis, necessitating lifelong management.
Findings:
- Colchicine provides significant symptomatic relief for FMF.
- Prolonged colchicine use demonstrates a remarkable safety profile.
- Effective even in pregnant women and children with minimal adverse effects.
Implications:
- Colchicine is a cornerstone therapy for managing FMF.
- Early diagnosis and continuous treatment are crucial for preventing complications like amyloidosis.
- Further research into FMF pathogenesis may reveal novel therapeutic targets.